Spontaneous fusion with macrophages empowers cancer cells to spread

Cancer cells that spontaneously fuse with macrophages, the immune system's healthy scavenger cells, play a key role in the metastasis, or spread of the cancer to other areas of the body, according to research to be presented Sunday, Dec. 15, at the American Society for Cell Biology annual meeting in New Orleans.

The researchers, Alain Silk, Ph.D., Melissa Wong, Ph.D., and at Oregon Health & Science University (OHSU) in Portland followed the work of German pathologist Otto Aichel, who suggested in 1911 that a cell under attack by a white blood cell might spontaneously fuse with that cell to produce a hybrid cell with chromosomal abnormalities that could lead to cancer.

Although Aichel's theory was dismissed by his contemporaries, recent discoveries about the broader role of in tissue homeostasis and regeneration have revived scientific interest in his ideas. Today there is strong evidence of fusion between cancer and normal cells in human cancer, but it has not been apparent whether cell fusion could provide cancer cells with a selective advantage that enhances cancer progression.

The OSHU researchers began by confirming that cells from various types of cancer could readily and spontaneously fuse with macrophages. By intensively studying the fusion-derived cancer cells, the researchers determined that these cells exhibited enhanced adhesive strength, formed tumors more rapidly than unfused cancer cells and flourished under conditions that dramatically inhibited growth of unfused cells.

"Overall, our findings demonstrate that spontaneous fusion of cancer cells with macrophages can profoundly and significantly impact the phenotype of tumorigenic cells, with implications for our basic understanding of cancer cell biology and the process of tumor evolution," the researchers said.

As cancer progresses, tumor cells acquire new capabilities, or phenotypes. They must grow in an uncontrolled manner, leave their site of origin and become resistant to anti-cancer drugs. Previous studies on the biology of cancer have revealed that cancer progression are determined by changes to the cancer genome, epigenetics, influences from the microenvironment, exosomes and the interplay with the immune system. The OSHU research implicates the fusion of with as a new potentiator of cancer progression.

More information: Author will present, "Spontaneous fusion with macrophages alters cancer cell phenotypes," on Sunday, Dec. 15, 2013 during the 12 noon to 1:30 p.m. ePoster Talk on, "Cancer Cell Biology and Tumor Microenvironment."

add to favorites email to friend print save as pdf

Related Stories

Anti-tumor activity of immune cells can be restored

Dec 10, 2013

The Leuven-based VIB researchers have revealed a mechanism that explains why the anti-tumor activity of specific immune cells called macrophages is suppressed during tumor growth. They have also demonstrated that blocking ...

How prostate cancer cells evolve

Dec 04, 2013

(Medical Xpress)—UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies. 

Recommended for you

Survival hope for melanoma patients thanks to new vaccine

56 minutes ago

(Medical Xpress)—University of Adelaide researchers have discovered that a new trial vaccine offers the most promising treatment to date for melanoma that has spread, with increased patient survival rates and improved ability ...

New clinical trial launched for advance lung cancer

4 hours ago

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer – marking a new era of research into personalised medicines ...

User comments